The Immunology of Buruli Ulcer
- PMID: 32091712
- Bookshelf ID: NBK553839
- DOI: 10.1007/978-3-030-11114-4_8
The Immunology of Buruli Ulcer
Excerpt
Buruli ulcer (BU) represents a unique human mycobacteriosis. Caused by Mycobacterium ulcerans, the disease spectrum is dominated by the activity of mycolactone, a dermanecrotic toxin that has shown the ability to interfere with the immune response. This poses an additional difficulty to the understanding of the immunological determinants for the outcome of infection, a fundamental step to develop better preventive or curative strategies. In this chapter, the immune response against M. ulcerans is reviewed, both with a series of clinical observations and experimental infection models and going through several other lines of evidence, including epidemiological and genetic studies. This holistic approach is expected to shed further light on the intriguing pathophysiology of this disease and help guide future research efforts.
Copyright 2019, The Author(s).
Sections
- 1. Buruli Ulcer: The First Histological Observations of a Necrotic Track
-
2. Host Attempts to Control
Mycobacterium ulcerans Infection - 3. Diagnostics Research Make it Evident: The Triggering of Cellular and Humoral Arms
- 4. Antibiotic Treatment in the Aid of the Host Immune Response
- 5. Epidemiological Clues and the Search for Novel Resistance and Susceptibility Markers
- 6. (Un)successful Preventive Approaches
- 7. Novel Models for Investigation and Future Perspectives
- 8. Conclusions
- Acknowledgements
- References
References
-
- Dodge OG (1964) Mycobacterial skin ulcers in Uganda: histopathological and experimental aspects. J Pathol Bacteriol 88:169–174 - PubMed
-
- MacCallum P, Tolhurst JC (1948) A new mycobacterial infection in man. J Pathol Bacteriol 60:93–122 - PubMed
-
- Connor DH, Lunn HF (1965) Mycobacterium ulcerans infection (with comments on pathogenesis). Int J Lepr 33(Suppl):698–709 - PubMed
Publication types
LinkOut - more resources
Full Text Sources